Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02188290 · ClinicalTrials.gov registry record
Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
A clinical trial, sponsored by Kiadis Pharma.
- Completed
- Registry status
- 178
- Enrollment target
NCT02188290 is a clinical trial that has completed, run by Kiadis Pharma. The registered enrollment target is 178 participants.
The verdict
NCT02188290 has completed, sponsored by Kiadis Pharma.
- COMPLETED
- Registry status
- 178 participants
- Enrollment target
Study Summary
Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02188290
The ClinicalTrials.gov registry entry for NCT02188290 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kiadis Pharma, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02188290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02188290 about?
NCT02188290 is a clinical study titled "Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation". Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).
What is the current status of trial NCT02188290?
This trial is currently completed. The enrollment target is 178 participants. The study started on 2014-09. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT02188290?
This trial is sponsored by Kiadis Pharma, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.